Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease.

Launched by POITIERS UNIVERSITY HOSPITAL · Jan 24, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring whether data from smartphones can help diagnose Alzheimer's disease and other memory disorders. Researchers want to see how smartphone usage differs among three groups of people: those who have memory complaints, those with mild cognitive decline, and those diagnosed with Alzheimer's disease. By comparing this data, the study aims to find out if smartphone activity can be a useful tool in identifying these conditions.

To be eligible for this study, participants need to be patients visiting a routine care center and must be able to use a smartphone without any sensory impairments. However, individuals with certain conditions, such as severe anxiety or other neurodegenerative diseases, will not be included. If you join the study, you can expect to share your smartphone usage data over a period of time, which will help researchers understand more about how technology might assist in diagnosing memory issues. The trial is currently recruiting participants of all genders, aged 21 and older.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient consulting in routine care in one of the CMRR
• • No sensory impairment that may compromise smartphone use
• Exclusion Criteria:
• • Inability to perform MMSE or MMSE \< 20 ;
• • Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis)
• • Severe anxiety or depressive disorder HADS score ≥ 17
• • Terminal phase of a severe disease
• • Evidence of a lesion on MRI that may be involved in cognitive impairment